In comparison with findings from our review of international research, there were greater concerns around the economic incentives around screening, the provision of social support, and the economic or social impacts of screening programmes.
The study concluded that, in combination with screening, the provision of hearing aids is least costly at primary care level (US$227 per child fitted), followed by secondary care level (US$277) and tertiary care level (US$365).
Using the best available evidence on reducing and preventing unplanned weight loss, the intervention (introducing universal nutritional screening; the provision of oral nutritional supplements; and providing red trays and additional support for patients in need of feeding) will be introduced by local ward teams in a phased way in a large tertiary acute care hospital.
The most significant barrier to screening was the provision of appropriate after-care; only one in three patients received treatment after a positive screen for distress [ 8].
Similarly, the value for money of screening and the provision of the day hospital intervention needs estimating.
Given the escalating vulnerabilities among refugees, UNICEF will reinforce nutritional screening and the provision of micronutrients and nutritional supplements, in particular for the most vulnerable children, youth and their families across the region.
Early booking enables the initiation of prenatal fetal and maternal screening and the provision of health advice on life-style issues during pregnancy, such as healthy nutrition, exercise, alcohol and smoking cessation amongst others.
Furthermore, from a health service perspective, if the approach in the proposed study were successful, it would support a case for balance screening and the provision of a balance training exercise programme as a routine component of early management for people diagnosed with Alzheimer's disease.
40 Secondly, most Western countries have developed breast cancer screening programmes but the provision of screening mammography varies markedly, with different settings (private practices versus national health services), ages of women screened, intervals between mammographic examinations, and numbers of mammographic views.
These were around the economic incentives for screening (profit motive), the provision of social support, and the economic/social impacts of screening programmes.
Moreover, hPSCs also offer a unique, novel platform by which to augment, and even redefine, current drug discovery and drug screening programmes by the provision of a human in vitro tool on which to perform efficacy and toxicity screens for novel chemical entities (NCEs) [ 4, 5].
